Radiofrequency ablation for slow-flow vascular malformations
Part of Blood & lymphatic, Genetic & congenital, Heart & circulation clinical trials.
This trial tests a procedure called radiofrequency ablation (RFA) to treat certain types of vascular malformations (abnormal blood or lymph vessels) that have slow blood flow. It may be an option for people who have symptoms like pain, swelling, or cosmetic concerns and are considering treatment instead of sclerotherapy (injecting medicine into the vessels).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 3 years old.
- You must have a slow-flow vascular malformation (like a lymphatic or venous malformation) confirmed by imaging (ultrasound or MRI).
- You must have symptoms such as pain, swelling, limited function, or cosmetic concerns, and want treatment.
- The malformation must be at least 3 mm below the skin and at least 3 mm away from important nerves or blood vessels.
- You must be able to have general anesthesia (being fully asleep during the procedure).
- You must agree to have radiofrequency ablation instead of sclerotherapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two targeted medicines for people with certain types of vascular malformations (abnormal blood vessels). If you have a slow-flow malformation, you may receive alpelisib; if you have a fast-flow malformation, you may receive mirdametinib. Genetic testing is needed to see if your malformation has a specific change that these drugs target.
This study looks at how patients with vascular anomalies (abnormal blood vessel growths) respond to certain medications. It aims to gather real-world information about their care to improve future treatment.
This trial tests if microwave ablation can safely treat painful or bothersome vascular malformations (abnormal blood vessel clusters). It helps people who have symptoms like pain, swelling, or ulcers that need treatment.
This trial tests a treatment called bleomycin electrosclerotherapy for people with slow-flow vascular malformations (abnormal blood vessels that do not flow quickly). The goal is to see if this treatment works well and is safe for these conditions.
This study is testing a treatment called electrosclerotherapy for low-flow venous malformations. It uses a medicine (bleomycin) injected into the abnormal blood vessels to shrink them. The goal is to see how well it works and how safe it is.
This trial tests a treatment called bleomycin electrosclerotherapy (BEST) for low-flow vascular malformations—abnormal blood vessel or lymph vessel growths that haven't responded well to previous treatments. The treatment involves injecting bleomycin (a medication) directly into the malformation and using electrical current to help destroy it.
Hear when a new Vascular Anomalies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.